Concepedia

HSD3B1 and resistance to androgen-deprivation therapy in prostate cancer: a retrospective, multicohort study

Jason W.D. Hearn, Ghada AbuAli, Chad A. Reichard, C.A. Reddy, Cristina Magi‐Galluzzi, Kai‐Hsiung Chang, Rachel E. Carlson, Laureano J. Rangel, Kevin Reagan, Brian J. Davis,

The Lancet Oncology · 2016 · 136 citations · 41 references

DOIFull text

Open access

Concepts

References

41

Increased Survival with Enzalutamide in Prostate Cancer after Chemotherapy

Howard I. Scher, Karim Fizazi, Fred Saad et al. · New England Journal of Medicine · 2012 · 4.6K citations · Full text

, , +14

Abiraterone and Increased Survival in Metastatic Prostate Cancer

Johann S. de Bono, Christopher J. Logothetis, Arturo Molina et al. · New England Journal of Medicine · 2011 · 4.4K citations · Full text

, , +17

Studies on Prostatic Cancer: I. The Effect of Castration, of Estrogen and of Androgen Injection on Serum Phosphatases in Metastatic Carcinoma of the Prostate

Charles Huggins, Clarence V. Hodges · The Journal of Urology · 2002 · 3.2K citations

, , +17

Enzalutamide in Metastatic Prostate Cancer before Chemotherapy

Tomasz M. Beer, Andrew J. Armstrong, Dana E. Rathkopf et al. · New England Journal of Medicine · 2014 · 3K citations · Full text

, , +17

Chemohormonal Therapy in Metastatic Hormone-Sensitive Prostate Cancer

Christopher J. Sweeney, Yu‐Hui Chen, Michael A. Carducci et al. · New England Journal of Medicine · 2015 · 2.8K citations · Full text

, , +15